Preferential Autoimmune Response in Prostate Cancer to Cyclin B1 in a Panel of Tumor-Associated Antigens

<table>Percentage of autoantibody responses to a panel of 15 TAAs. The percentages refer to antibody titers exceeding the mean + 3SD of normal human sera from ELISA. In this panel of 15 TAAs, the highest reactivity antigen was cyclin B1.</table>

Journal of Immunology Research

fig3

Figure 3

Figure 3: Preferential Autoimmune Response in Prostate Cancer to Cyclin B1 in a Panel of Tumor-Associated Antigens 